TC-A101

News alerts, weekly reports and conference planners

Company:

TCRCure, Xinqiao Hospital

Drug class:

ALPP-targeted CAR-T immunotherapy

Related drugs:

‹

›

ALPP expression	Endometrial Cancer	ALPP expression	Endometrial Cancer	TC-A101 Sensitive: C3 – Early Trials TC-A101 Sensitive : C3	TC-A101 Sensitive: C3 – Early Trials TC-A101 Sensitive : C3
ALPP expression	Ovarian Cancer	ALPP expression	Ovarian Cancer	TC-A101 Sensitive: C3 – Early Trials TC-A101 Sensitive : C3	TC-A101 Sensitive: C3 – Early Trials TC-A101 Sensitive : C3

Associations
(2)